| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |